Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 6 de ago. de 2022 · There is currently no cure for Crohn's disease, and there is no single treatment that works for everyone. One goal of medical treatment is to reduce the inflammation that triggers your signs and symptoms.

  2. Doctors treat Crohn’s disease with medicines, bowel rest, and surgery. No single treatment works for everyone with Crohn’s disease. The goals of treatment are to decrease the inflammation in your intestines, to prevent flare-ups of your symptoms, and to keep you in remission.

  3. 5 de abr. de 2024 · The 20 Best Crohn's Disease Doctors Near Me | MediFind. Refine your search results with filters. Specialty. Additional Specialty. Distance: Gender. Availability. Years of Experience. Level of Expertise. Reset all. Last Updated: 04/05/2024. Looking for the best doctor for you? Start Here. Learn about our expert tiers. Learn more.

  4. 6 de ago. de 2022 · Doctors who treat this condition. Narrow your search. By location. By last name. Reset all filters. Displaying 1-10 out of 29 doctors available. Jana G. Al Hashash, M.D., M.S. Gastroenterologist. Jacksonville, FL. Areas of focus: Colonoscopy, Upper endoscopy, Chromoendoscopy, Ulcerative colitis, Crohn's disease, Gastrointestinal bleeding, Pouchitis

  5. 29 de may. de 2020 · Introduction and background. Crohn’s disease (CD) is an idiopathic inflammatory disorder. It is influenced by genetics, the environment, and immunologic milieu. The incidence of this disease is increasing and treatment options are always evolving.

  6. Find a Medical Expert. Search our database of Crohn's & Colitis Foundation Professional Members: leading IBD doctors, researchers, nurses, advanced practice providers, surgeons, dietitians, mental health providers, and other healthcare professionals.

  7. 17 de feb. de 2022 · Anti-TNF drugs are highly effective in the management of CD but treatment failure is a common downfall to these medications. The personalised anti-TNF therapy in Crohns disease study (PANTS) aimed to identify specific clinical and pharmacokinetic factors that predicted primary non-response.